Intra-operative STN DBS attenuates the prominent beta rhythm in the STN in Parkinson's disease

被引:200
作者
Wingeier, B
Tcheng, T
Koop, MM
Hill, BC
Heit, G
Bronte-Stewart, HM
机构
[1] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA
[2] Stanford Univ, Inst Neurosci, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA
[4] NeuroPace Inc, Mountain View, CA USA
关键词
Parkinson's disease; subthalamic nucleus; deep brain stimulation; beta rhythm; neuronal oscillations;
D O I
10.1016/j.expneurol.2005.09.016
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Power spectra From local Field potentials (LFPs) recorded post-operatively from the deep brain Stimulation (DBS) macroelectrode show prominence of the beta rhythm (11-30 Hz) in untreated Parkinson's disease (PD). Dopaminergic medication and movement attenuate this beta band in PD. In this pilot study of six sides ill four patients, we recorded LFPs from the DBS electrode in untreated PD patients in the operating room. In all cases, there was a peak in the time-frequency spectrogram in the beta frequency range when the patients were at rest, which was associated with attenuation in the same range with movement. The actual frequency range and the strength of the beta peak varied among cases. In two patients, intra-operative constraints permitted recording of LFPs at rest, before and immediately after subthalamic nucleus (STN) DBS. In both patients we documented that STN DBS caused a significant attenuation ill power in the beta band at rest that persisted for 15-25 s after DBS had been turned off (P < 0.01). From one case, our data suggest that the beta rhythm attenuation was most prominent within the STN itself. This study shows for the first time that STN DBS attenuates the power in the prominent beta band recorded in the STN of patients with PD. These pilot findings raise the interesting possibility of using this biomarker for closed loop DBS or neuromodulation. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:244 / 251
页数:8
相关论文
共 37 条
[31]   Microelectrode recording revealing a somatotopic body map in the subthalamic nucleus in humans with Parkinson disease [J].
Romanelli, P ;
Heit, G ;
Hill, BC ;
Kraus, A ;
Hastie, T ;
Brontë-Stewart, HM .
JOURNAL OF NEUROSURGERY, 2004, 100 (04) :611-618
[32]  
TAVARES AT, 2005, MOV DISORD
[33]   PALLIDAL AND TEGMENTAL INHIBITION OF OSCILLATORY SLOW WAVES AND UNIT ACTIVITY IN SUBTHALAMIC NUCLEIS [J].
TSUBOKAWA, T ;
SUTIN, J .
BRAIN RESEARCH, 1972, 41 (01) :101-+
[34]   Microelectrode-guided pallidotomy: technical approach and its application in medically intractable Parkinson's disease [J].
Vitek, JL ;
Bakay, RAE ;
Hashimoto, T ;
Kaneoke, Y ;
Mewes, K ;
Zhang, JY ;
Rye, D ;
Starr, P ;
Baron, M ;
Turner, R ;
DeLong, MR .
JOURNAL OF NEUROSURGERY, 1998, 88 (06) :1027-1043
[35]   THE PRIMATE SUBTHALAMIC NUCLEUS .1. FUNCTIONAL-PROPERTIES IN INTACT ANIMALS [J].
WICHMANN, T ;
BERGMAN, H ;
DELONG, MR .
JOURNAL OF NEUROPHYSIOLOGY, 1994, 72 (02) :494-506
[36]   Functional and pathophysiological models of the basal ganglia [J].
Wichmann, T ;
DeLong, MR .
CURRENT OPINION IN NEUROBIOLOGY, 1996, 6 (06) :751-758
[37]   Dopamine-dependent changes in the functional connectivity between basal ganglia and cerebral cortex in humans [J].
Williams, D ;
Tijssen, M ;
van Bruggen, G ;
Bosch, A ;
Insola, A ;
Di Lazzaro, V ;
Mazzone, P ;
Oliviero, A ;
Quartarone, A ;
Speelman, H ;
Brown, P .
BRAIN, 2002, 125 :1558-1569